These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 10709911

  • 1. The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation.
    Liang JF, Li Y, Yang VC.
    Thromb Res; 2000 Mar 01; 97(5):349-58. PubMed ID: 10709911
    [Abstract] [Full Text] [Related]

  • 2. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
    Andrade-Gordon P, Strickland S.
    Biochemistry; 1986 Jul 15; 25(14):4033-40. PubMed ID: 2943315
    [Abstract] [Full Text] [Related]

  • 3. The effect of fucoidan, heparin and cyanogen bromide-fibrinogen on the activation of human glutamic-plasminogen by tissue plasminogen activator.
    Bell J, Duhon S, Doctor VM.
    Blood Coagul Fibrinolysis; 2003 Apr 15; 14(3):229-34. PubMed ID: 12695744
    [Abstract] [Full Text] [Related]

  • 4. The effects of polysaccharides on plasminogen activation by single chain-and two chain-tissue plasminogen activator.
    Kawamura H, Watanabe I, Urano T, Takada Y, Takada A.
    Thromb Res; 1991 Jun 01; 62(5):481-90. PubMed ID: 1654600
    [Abstract] [Full Text] [Related]

  • 5. Heparin oligosaccharides enhance tissue-type plasminogen activator: a correlation between oligosaccharide length and stimulation of plasminogen activation.
    Edelberg JM, Conrad HE, Pizzo SV.
    Biochemistry; 1991 Nov 12; 30(45):10999-1003. PubMed ID: 1932024
    [Abstract] [Full Text] [Related]

  • 6. Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation.
    Edelberg JM, Pizzo SV.
    Biochemistry; 1990 Jun 26; 29(25):5906-11. PubMed ID: 2143417
    [Abstract] [Full Text] [Related]

  • 7. The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a).
    Edelberg JM, Reilly CF, Pizzo SV.
    J Biol Chem; 1991 Apr 25; 266(12):7488-93. PubMed ID: 1708387
    [Abstract] [Full Text] [Related]

  • 8. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin.
    Soeda S, Kakiki M, Shimeno H, Nagamatsu A.
    Biochim Biophys Acta; 1987 Dec 18; 916(3):279-87. PubMed ID: 3120775
    [Abstract] [Full Text] [Related]

  • 9. Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin.
    Patston PA, Schapira M.
    Blood; 1994 Aug 15; 84(4):1164-72. PubMed ID: 8049432
    [Abstract] [Full Text] [Related]

  • 10. Study on the mechanism of action of heparin and related substances on the fibrinolytic system: relationship between plasminogen activators and heparin.
    Pâques EP, Stöhr HA, Heimburger N.
    Thromb Res; 1986 Jun 15; 42(6):797-807. PubMed ID: 3088755
    [Abstract] [Full Text] [Related]

  • 11. Ionic modulation of the effects of heparin on plasminogen activation by tissue plasminogen activator: the effects of ionic strength, divalent cations, and chloride.
    Young TN, Edelberg JM, Stack S, Pizzo SV.
    Arch Biochem Biophys; 1992 Aug 01; 296(2):530-8. PubMed ID: 1385938
    [Abstract] [Full Text] [Related]

  • 12. Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator.
    Edelberg JM, Gonzalez-Gronow M, Pizzo SV.
    Thromb Res; 1990 Jan 01; 57(1):155-62. PubMed ID: 2137266
    [No Abstract] [Full Text] [Related]

  • 13. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH, Diamond SL.
    Thromb Haemost; 1995 Aug 01; 74(2):711-7. PubMed ID: 8585011
    [Abstract] [Full Text] [Related]

  • 14. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.
    Nishino T, Yamauchi T, Horie M, Nagumo T, Suzuki H.
    Thromb Res; 2000 Sep 15; 99(6):623-34. PubMed ID: 10974349
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen and tissue plasminogen activator interact with antithrombin III.
    Dudani AK.
    Thromb Res; 2000 Sep 15; 99(6):635-41. PubMed ID: 10974350
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of the stimulatory effect of native fucoidan, highly sulfated fucoidan and heparin on plasminogen activation by tissue plasminogen activator: the role of chloride.
    Lang D, Williams T, Phillips A, Doctor VM.
    Eur J Drug Metab Pharmacokinet; 2004 Sep 15; 29(4):269-75. PubMed ID: 15726889
    [Abstract] [Full Text] [Related]

  • 17. Aggregated, conformationally changed fibrinogen exposes the stimulating sites for t-PA-catalysed plasminogen activation.
    Haddeland U, Sletten K, Bennick A, Nieuwenhuizen W, Brosstad F.
    Thromb Haemost; 1996 Feb 15; 75(2):326-31. PubMed ID: 8815585
    [Abstract] [Full Text] [Related]

  • 18. Interaction of reteplase with heparin. A comparison between reteplase and alteplase.
    Rijken DC, Jie AF.
    Blood Coagul Fibrinolysis; 1996 Jul 15; 7(5):561-6. PubMed ID: 8874867
    [Abstract] [Full Text] [Related]

  • 19. Effects of heparan sulfate analogue or other sulfated polysaccharides on the activation of plasminogen by t-PA or u-PA.
    Takada Y, Urano T, Takada A.
    Thromb Res; 1994 Mar 01; 73(5):301-11. PubMed ID: 8016815
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and characterization of positively charged tPA as a prodrug using heparin/protamine-based drug delivery system.
    Liang JF, Li YT, Connell ME, Yang VC.
    AAPS PharmSci; 2000 Mar 01; 2(1):E7. PubMed ID: 11741223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.